Avanos Medical stockholders elect all five director nominees, ratify auditor, approve say-on-pay

AVANOS MEDICAL, INC.

Elected directors: Gary Blackford, Lisa Egbuonu-Davis, Patrick O'Leary, Julie Shimer, Joseph Woody; each received over 39M votes for.
Ratified Deloitte & Touche as independent auditor for 2024 with 42.5M votes for vs 435k against.
Advisory vote on NEO compensation approved with 38.5M votes for, 2.1M against, and 2.3M broker non-votes.
About 93% of outstanding shares represented (42.99M shares) at the April 25, 2024 Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

AVANOS MEDICAL, INC. shareholders approved To approve, on an advisory basis, the compensation of the Company’s named executive officers at the 2024-04-25 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2024-04-25

Exact text from the filing

The votes cast on Proposal No. 3 were as follows: For Against Abstain Broker non-votes Approval of NEO compensation 38,515,084 2,104,432 57,555 2,312,795

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

AVANOS MEDICAL, INC. shareholders approved To elect Gary D. Blackford, Dr. Lisa Egbuonu-Davis, Patrick J. O’Leary, Dr. Julie Shimer and Joseph F. Woody to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders at the 2024-04-25 meeting.

Proposal: director election
Outcome: passed
Meeting: 2024-04-25

Exact text from the filing

The votes cast on Proposal No. 1 were as follows: Director For Withhold Broker non-votes Gary D. Blackford 39,916,596 760,475 2,312,795 Dr. Lisa Egbuonu-Davis 39,845,016 832,055 2,312,795 Patrick J. O’Leary 40,149,326 527,745 2,312,795 Dr. Julie Shimer 39,726,238 950,833 2,312,795 Joseph F. Woody 40,385,119 291,952 2,312,795

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

AVANOS MEDICAL, INC. shareholders approved To ratify the appointment of Deloitte & Touche LLP as the Company’s independent auditors for 2024 at the 2024-04-25 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2024-04-25

Exact text from the filing

The votes cast on Proposal No. 2 were as follows: For Against Abstain Appointment of Deloitte & Touche LLP 42,503,768 435,813 50,285

View on SEC.gov

550 shareholder votes filed in the last 30 days. Browse all shareholder votes →

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-24-000053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.